Navigation Links
Misonix, Inc. To Report Financial Results For The First Quarter Of Fiscal Year 2014 On Thursday, November 7, 2013
Date:11/4/2013

FARMINGDALE, N.Y., Nov. 4, 2013 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the first quarter of fiscal year 2014 ended September 30, 2013 on Thursday, November 7, 2013. The Company has scheduled a conference call that same day, Thursday, November 7, 2013, at 4:30 pm ET to review the results.

Interested parties can access the conference call by dialing (877) 317-6789 or (412) 317-6789 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company's website at www.misonix.com.

A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation # 10036674. A webcast replay will be available in the Investor Relations section of the Company's website at www.misonix.com for 30 days.

About MisonixMisonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Safe Harbor StatementWith the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.Misonix Contact:

Investor Contact: Richard Zaremba

Joe Diaz 631-694-9555 Lytham Partners invest@misonix.com 602-889-9700info@misonix.com


'/>"/>
SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix, Inc. Announces Fourth Quarter and Fiscal Year 2013 Financial Results
2. Misonix, Inc. Announces the Grant of Patent by the United States Patent and Trademark Office
3. InspireMD to Report Financial Results for Quarter Ending September 30, 2013 on Monday, November 11, 2013
4. Mast Therapeutics Reports Third Quarter 2013 Financial Results
5. Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results
6. Sellers of Unapproved Drugs Proliferate Online, Posing a Serious Threat to Global Public Health, Reports NABP
7. Four-Star Gen. Barry McCaffrey, Former US Drug Czar, To Report "Drugs In The Workplace -- Understated National Crisis" At Teamsters Health & Benefits Forum Fri., Nov. 8, 10:30 AM At NYC Grand Hyatt
8. Cambrex Reports Third Quarter 2013 Financial Results
9. IRIDEX Reports 2013 Third Quarter Results
10. Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
11. Concord Medical to Report Third Quarter 2013 Financial Results on November 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2017)... Inc., a biotechnology company focused on the development of novel ... and Head of Virology Kristin Bedard has been invited to ... Beyond meeting sponsored by Life Science Washington.  This Symposium ... PDT at the Agora Conference Center in Seattle, ... joined by other leaders in infectious disease research and the ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite ... that a two year study conducted by the University of Saskatchewan in partnership ... in remediating potash brine-impacted groundwater. As a part of the study, batch adsorption ...
(Date:6/28/2017)... ... 2017 , ... Doner Financial, a Cincinnati area firm that ... and financial planning services, is announcing the commencement of a local charity event ... financial crisis. , Matthew 25: Ministries (M25M) is an international organization dedicated to ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with ... lodgings for families with children receiving treatment in nearby hospitals. , Ronald McDonald ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... according to survey data released today by the American Society for Dermatologic ... indicates the percentage of consumers considering a cosmetic medical procedure has doubled ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a ... assets on the Ethereum blockchain, has released their technical specifications . , 2017 ... has been little systematic approach for determining which offerings will garner the greatest ROI. ...
Breaking Medicine News(10 mins):